HPV Academy > Vắc xin HPV > Câu hỏi thường gặp
CÂU HỎI THƯỜNG GẶP
Danh mục
Gánh nặng bệnh tật do HPV
1. Cancer today. https://gco.iarc.fr/today/home
2. Forman D et al (2012). Global burden of HPV and related diseases. Vaccine; 30S:F12-F23. https://pubmed.ncbi.nlm.nih.gov/23199955/
3. Patel et al (2013). Systematic review of the incidence and prevalence of genital warts. BMC Infectious Diseases, 13:39. https://pubmed.ncbi.nlm.nih.gov/23347441/
4. Braaten KP et al (2008). Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine. Rev Obstet Gynecol,1:2–10. https://pubmed.ncbi.nlm.nih.gov/18701931/
5. Hoots BE et al (2009). Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer, 124:2375–2383. https://pubmed.ncbi.nlm.nih.gov/19189402/
6. IARC. IARC monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses. Vol 90. Lyon, France: IARC, 2007. HPV https://pubmed.ncbi.nlm.nih.gov/18354839/
Các týp HPV nguy cơ cao
Các týp HPV nguy cơ thấp
1. De Sanjosé S et al (2010). Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol, 11:1048–1056. https://pubmed.ncbi.nlm.nih.gov/20952254/
2. De Sanjosé S et al (2013). Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer, 49:3450–3461. https://pubmed.ncbi.nlm.nih.gov/23886586/
3. Alemany L et al (2014). Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. Eur J Cancer, 50:2846–2854. https://pubmed.ncbi.nlm.nih.gov/25155250/
4. Alemany L et al (2015). Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer, 136:98–107.
https://pubmed.ncbi.nlm.nih.gov/24817381/
5. Joura EA et al (2014). Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease. Cancer Epidemiol Biomarkers Prev, 23:1997–2008. https://pubmed.ncbi.nlm.nih.gov/25274978/
6. Garland SM et al (2009). Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis, 199:805–814. https://pubmed.ncbi.nlm.nih.gov/19199546/
7. Guan P et al (2012). Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer, 131:2349–2359. https://pubmed.ncbi.nlm.nih.gov/22323075/
8. Alemany L et al (2016). Role of Human Papillomavirus in Penile Carcinomas Worldwide. Eur Urol, 69:953–961. https://pubmed.ncbi.nlm.nih.gov/26762611/
9. Alemany L. Presented at EUROGIN 2017 Amsterdam, the Netherlands.
1. Bharti AC. et al (2018). Therapeutic strategies for human papillomavirus infection and associated cancers. Frontiers in Bioscience, 10: 15–73.
https://pubmed.ncbi.nlm.nih.gov/28930604/
2. Wierzbicka M. et al (2022). Transmission and clearance of human papillomavirus infection in the oral cavity and its role in oropharyngeal carcinoma – A review. Rev Med Virol, e2337. https://pubmed.ncbi.nlm.nih.gov/35194874/
3. Petca A. et al (2020). Non-sexual HPV transmission and role of vaccination for a better future. Experimental and Therapeutic Medicine, 186: 1–5.
https://pubmed.ncbi.nlm.nih.gov/33101476/
Người có nguy cơ cao bị nhiễm hpv là các đối tượng:
1. Bharti AC et al (2018). Therapeutic strategies for human papillomavirus infection and associated cancers. Frontiers in Bioscience, 10: 15–73. https://doi.org/10.2741/e808
2. Wierzbicka M. et al (2022). Transmission and clearance of human papillomavirus infection in the oral cavity and its role in oropharyngeal carcinoma – A review. Rev Med Virol, e2337. https://doi.org/10.1002/rmv.2337
3. Janet G. Baseman, Laura A. Koutsky et al (2005). The epidemiology of human papillomavirus infections. Journal of Clinical Virology, 32 Suppl 1:S16–24. https://pubmed.ncbi.nlm.nih.gov/15753008/
4. Stuart Collins et al (2002). High incidence of cervical human papillomavirus infection in women during their first sexual relationship. BJOG, 109(1):96–8. https://pubmed.ncbi.nlm.nih.gov/11845815/
5. Rachel L Winer et al (2008). Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis, 15;197(2):279–82.
https://pubmed.ncbi.nlm.nih.gov/18179386/
6. Maria Inmaculada Rodríguez-Álvarez et al (2018). Prevalence and Risk Factors of Human Papillomavirus in Male Patients: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health, 10;15(10):2210. https://pubmed.ncbi.nlm.nih.gov/30309014/
7. Jessica A Kahn et al (2002). Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics, 109(1):E5. https://pubmed.ncbi.nlm.nih.gov/11773573/
8. Marc Arbyn et al (2018). Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev, 9;5(5):CD009069. https://pubmed.ncbi.nlm.nih.gov/29740819/
1. IARC Publications Website – Human Papillomaviruses.
https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Human-Papillomaviruses-2007
2. Michelle S. Longworth et al (2004). Pathogenesis of Human Papillomaviruses in Differentiating Epithelia. Microbiology and Molecular Biology Reviews, p.362–372.
https://doi.org/10.1128%2FMMBR.68.2.362-372.2004
3. Joseph J. Carter, Laura A. Koutsky, James P. Hughes et al (2000). Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. The Journal of Infectious Diseases, 181(6), pp.1911–1919.
https://doi.org/10.1086/315498
4. Helen Trottier, Silvaneide Ferreira, Patricia Thomann et al (2010). HPV infection and re-infection in adult women: the role of sexual activity and natural immunity. Cancer Res, 70(21): 8569–8577.
https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=20978200
5. Anna R. Giuliano, Raphael Viscidi, B. Nelson Torres et al (2015). Seroconversion following anal and genital HPV infection in men: The HIM study. Papillomavirus Research, 1, 109–115.
http://dx.doi.org/10.1016/j.pvr.2015.06.007
6. Sylvia L. Ranjeva, Edward B. Baskerville, Vanja Dukic et al (2017). Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity. PNAS, 114(51): 13573–13578.
http://www.pnas.org/cgi/doi/10.1073/pnas.1714712114
1. Bộ Y tế Việt Nam, 2021. Quyết định 1639/QĐ-BYT về việc ban hành tài liệu bổ sung hướng dẫn hoạt động dự phòng, sàng lọc phát hiện sớm và quản lý ung thư vú, ung thư cổ tử cung tại cộng đồng thuộc đề án 818 đến năm 2030. Quyết định 1639/QĐ-BYT 2021 Tài liệu sàng lọc ung thư vú ung thư cổ tử cung tại cộng đồng (thuvienphapluat.vn)
2. Bộ Y tế Việt Nam, 2019. Quyết định 2402/QĐ-BYT về việc phê duyệt tài liệu hướng dẫn dự phòng và kiểm soát ung thư cổ tử cung. Hướng dẫn dự phòng và Kiểm soát ung thư cổ tử cung – (moh.gov.vn)
3. WHO. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 6 July 2021.
ISBN: 978 92 4 003082 4. https://www.who.int/publications/i/item/9789240030824
4. CDC. Genital HPV Infection – Basic Fact Sheet. https://www.cdc.gov/std/hpv/stdfact-hpv.htm
5. CDC. Sexually Transmitted Diseases (STDs) Treatment Guidelines, 2021. Human Papillomavirus (HPV) Infection. https://www.cdc.gov/std/treatment-guidelines/STI-Guidelines-2021.pdf
1. Koliopoulos G, et al (2017). Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database of Systematic Reviews 2017. https://pubmed.ncbi.nlm.nih.gov/28796882/
2. Khan MJ, et al (2005). The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst, 97:1072–1079. https://pubmed.ncbi.nlm.nih.gov/16030305/
3. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition 2021. https://www.who.int/publications/i/item/9789240030824
4. Fontham ETH et al (2020). Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin, 70:321–346. https://pubmed.ncbi.nlm.nih.gov/32729638/
5. Hướng dẫn của Bộ Y tế (Số 2402/QĐ-BYT ngày 10/06/19) về tầm soát ung thư cổ tử cung.
6. ACOG (2021). Updated Cervical Cancer Screening Guidelines. Available at: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated-cervical-cancer-screening-guidelines
7. Stanley M et al (2010). HPV – immune response to infection and vaccination. Infectious Agents and Cancer, 5:19.
https://pubmed.ncbi.nlm.nih.gov/20961432/
THƯ VIỆN KHOA HỌC VÀ THỰC HÀNH
Hiểu về HPV
Tìm hiểu bức tranh tổng quan về HPV, từ đặc điểm sinh bệnh học, phương thức lây truyền đến dữ liệu dịch tễ trong cộng đồng
Ung thư và bệnh lý liên quan đến HPV
Tìm hiểu ung thư và các bệnh lý liên quan đến HPV, từ biểu hiện lâm sàng đến dự phòng và điều trị
Vắc xin HPV
Tìm hiểu về vắc xin HPV và những tài liệu chuyên môn hướng dẫn dự phòng và kiểm soát các bệnh lý, ung thư liên quan HPV
Tư vấn dự phòng HPV
Tìm hiểu kỹ thuật tư vấn dự phòng HPV và gợi ý trả lời một số câu hỏi thường gặp, hỗ trợ cán bộ y tế nâng cao hiệu quả và rút ngắn thời gian trong quá trình tư vấn
VN-GSL-02783 14072027